AVB's Q3 update may show resilient revenues and occupancy in premium markets despite higher costs and softer rent growth.

Revenue was up 5% in the quarter driven by broad-based shipment growth in short cycle components, continued strength across ...

Fresh Biotech information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.